期刊文献+

缓激肽β_2受体基因启动子区-58T/C多态性与哈萨克族人原发性高血压的相关性分析 被引量:8

Association of Genetic Variants in the Promoter Region of the β_2 Bradykinin Receptor Gene and Essential Hypertension in Kazakans of Xinjiang
原文传递
导出
摘要 目的探讨在新疆哈萨克民族中缓激肽β2受体基因启动子区-58位基因多态性与原发性高血压的关系。方法运用聚合酶链反应-单链构象多态性分析(PCR-SSCP)、克隆测序等方法,对354例收缩压≥140mmHg和(或)舒张压≥90mmHg的原发性高血压哈萨克族患者和216例年龄、性别、族别相匹配的血压<140/90mmHg的正常血压者,分别进行缓激肽β2受体基因启动子区-58位基因多态性检测,观察不同基因型和等位基因频率在高血压患者组和正常血压对照组中的分布。结果新疆哈萨克族人缓激肽β2受体基因启动子区-58位存在TT、CC、TC3种基因型,各基因型在原发性高血压患者组和正常血压对照组的分布频率分别为0·29、0·29,0·15、0·22,0·56、0·49。T、C两种等位基因的分布频率分别为0·53、0·47和0·57、0·43。3种基因型和等位基因频率分布在两组间无统计学差异。结论新疆哈萨克族人缓激肽β2受体基因启动子区-58位基因多态性可能与哈萨克族人原发性高血压不相关。 Objective To investigate the association between the genetic variants in the promoter region of bradykinin β2receptor gene and the essential hypertension in Kazakans of Xinjiang. Method A total of 354 hypertensive patients (SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg) and 216 normotensive controls ( BP 〈 140/90 mmHg) controlled for age, sex, nationality from Kazakans of Xinjiang were studied. The genetic variants was measured by PCR-SSCP, cloned and sequenced in hypertensive patients and normotensive controls respectively. Result Three genotypes (TT, CC, TC) were detected and the distribution frequencies of genotypes TT, CC, TC were 0, 29, 0. 15, 0.56 and 0.29, 0.22, 0.49 in hypertensive group and normotensive group respectively. The distribution frequencies of T and C allele were 0.57, 0.43 in hypertensive patients and 0.53, 0.47 in controls respectively. Both of genotypes and allele frequencies showed no significant differences between the two groups. Conclusion The -58T/C polymorphism in the promoter region of bradykinin β2 receptor gene in Kazakans of Xinjiang may not be associated with essential hypertension.
出处 《医学分子生物学杂志》 CAS CSCD 2008年第2期110-113,共4页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30260038 30240045) 新疆自治区重点科技项目(No.200633129)~~
关键词 高血压 缓激肽β2受体基因 基因多态性 哈萨克族 hypertension bradykininβ2receptor gene gene polymorphorism Kazakans
  • 相关文献

参考文献13

  • 1[1]DUKA A,DUKA I,GAO G,et al.Role of bradykinin B1 and B2 receptors in normal blood pressure regulation.[J].Am J Physiol Endocrinol Metab,2006,291 (2):E268-274.
  • 2[2]BRAUN A.MAIER S.KAMMERER S,et al.A novel sequence polymorphism in the promoter region of the human β2 bradykinin receptor gene[J].Hum Genet,1996,97:688-689.
  • 3[3]GAINER J V,BROWN N J,BACHVAROVA M,et al.Altered frequency of a promoter polymorphism of the kinin β2 receptor gene in hypertensive Afrecan-Americans[J].Am J Hyperten,2000,13 (12):1268-1273.
  • 4[4]MUKAE S,AOKI S,ITOH S,et al.Promoter polymorphisim of the 2 bradykinin receptor geng is associated with essential hypertension[J].Jpn Circ J,1999,63:759-762.
  • 5王兵,刘国仗,党爱民.缓激肽β_2受体基因启动子区点突变与高血压病的关系[J].中华心血管病杂志,2001,29(4):203-205. 被引量:18
  • 6[6]MORAES M R,BACURAU RF,RAMALHO J D,el al.Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers[J].Biol Chem,2007,388 (5):533-540.
  • 7[7]HESS J F,BORKOWSKI J A,YOUNG G S,et al.Cloning and pharmacological characterization of a human bradykinin receptor[J].Biochem Biophys Res Commun,1992,184:260-268.
  • 8[8]BRAUN A,KAMMERER S,BOHME E,et al.Identification of polymorphism sites of the human bradykinin B2 receptor gene[J].Biochem biophys Res Commun,1995,211:234-240.
  • 9[9]BRAUM A,KAMMERER S,MAIER E,et al.Polymorphisms in the gene for the human β2-bradykinin receptor.new tool in assessing a genetic risk for bradykinin-associated diseases[J].Immunopharmacology,1996,33:32-35.
  • 10[10]FU Y,KATSUYA T,MATSUO A,et al.Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy[J].Hypertens Res,2004,27 (12):933-938.

二级参考文献14

  • 1全国血压抽样调查协作组.中国各民族高血压患病情况调查[J].高血压杂志,1995,3(A01):24-30. 被引量:38
  • 2全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 3Linz W,Pharmacol Rev,1995年,47卷,25页
  • 4Hess J F,Biochem Biophys Res Commun,1992年,184卷,260页
  • 5程祖亨 汪师贞.新疆维吾尔自治区不同民族高血压流行病学因素的调查研究[J].新疆医学院学报,1982,5:103-114.
  • 6Yamori Y, Nara Y, Nutritional factors for hypertension and major cardiovascular disease: International cooperative studies for dietary prevention [J] . DMWJpn. 1994, 16: 1825~1841.
  • 7Wu Yingkai, Lu Changqing, Gao Runquan, et al. Nation- Wide Hypertension Screeningin China during 1979~ 1980[J ]. Chinese Medical Journal, 1982, 95: 101~108.
  • 8WHO MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease) : A major international Collaboration[J]. J ClinEpideiol, 1988, 41: 105-114.
  • 9Guidelines Subcommittee of the World Health Organization-International Society of Hypertension Mild Hypertension Liaison Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J]. Journal of Hypertension 1999, 17: 151-183.
  • 10Hypertension Prevalence and Status of Awareness, Treatment and Control in China, Tao Shouqi , Wu Xigui , Duan Xiufang et al [J] . Chinese Medical Journal, 1995, 108 (7) : 483~489.

共引文献111

同被引文献177

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部